Buscar

Estamos realizando la búsqueda. Por favor, espere...

Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of...

Abstract: The immunosuppressive treatment that recipients receive from a solid organ transplantation hinders the defensive response to infection. Its transmission from the donor can cause dysfunction or loss of the graft and even death of the recipient if proper preventive measures are not established. This potential risk should be thoroughly evaluated to minimise the risk of infection transmission from donor to recipient, especially with organ transplantation from donors with infections, without increasing graft dysfunction and morbidity and mortality in the recipient. This document aims to review current knowledge about infection screening in potential donors and offer clinical and microbiological recommendations about the use of organs from donors with infection based on available scientific evidence.

 Fuente: Enferm Infecc Microbiol Clin . 2020 Oct;38(8):379-389

 Editorial: Doyma

 Fecha de publicación: 01/10/2020

 Nº de páginas: 11

 Tipo de publicación: Artículo de Revista

 DOI: 10.1016/j.eimc.2019.10.016

 ISSN: 0213-005X,1578-1852

 Proyecto español: REIPI RD16/0016

 Url de la publicación: https://doi.org/10.1016/j.eimc.2019.10.016

Autoría

LEN, ÓSCAR

LOS-ARCOS, IBAI

AGUADO, JOSÉ MARÍA

BLANES, MARINO

BODRO, MARTA

CARRATALÀ, JORDI

FERNÁNDEZ RUIZ, MARIO

TRANSPLANT INFECTION STUDY GROUP GESITRA